Add Yahoo as a preferred source to see more of our stories on Google. Convicted killer Wade Wilson's journey to Florida's death row is documented in detail in the new Paramount+ docuseries "Handsome ...

A new docuseries explores the case of Wade Wilson, who was sentenced to death for two 2019 murders. The series, "Handsome Devil: Charming Killer," examines how Wilson gained an online following ...

An iconic Missouri city has been named one of the most charming small towns in America by HGTV. The lifestyle television network compiled its list by considering each state's hidden gems that offer ...

Jasen Kaplan, who was known for his appearance on Finding Prince Charming, has died. He was 46. The celebrity makeup artist died shortly before midnight on Wednesday in a New York City hospital as the ...

Some tech leaders are concerned that the artificial intelligence race will exhaust available land and energy. The solution might lie in orbit. Credit...Soña Lee Supported by By Eli Tan and Ryan Mac ...

More than $61 billion has flowed into the data center market so far this year. Hyperscalers are increasingly turning to outside capital in the form of debt to fund the energy-intensive infrastructure.

This coal plant in central Pennsylvania, once the largest in the state, was shuttered in 2023 after powering the region for over 50 years. Earlier this year, wrecking crews blasted the plant’s cooling ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Chad Spodick, who was featured on the LGBT dating reality series “Finding Prince Charming,” has died. A 911 recording obtained by TMZ reveals that Spodick died by hanging in a backyard. His mother, ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...